ATE519777T1 - Magnetosomen-genexpression in eukaryotischen zellen - Google Patents

Magnetosomen-genexpression in eukaryotischen zellen

Info

Publication number
ATE519777T1
ATE519777T1 AT07719932T AT07719932T ATE519777T1 AT E519777 T1 ATE519777 T1 AT E519777T1 AT 07719932 T AT07719932 T AT 07719932T AT 07719932 T AT07719932 T AT 07719932T AT E519777 T1 ATE519777 T1 AT E519777T1
Authority
AT
Austria
Prior art keywords
eukaryotic cells
gene expression
magnetosome
magnetosome gene
structures
Prior art date
Application number
AT07719932T
Other languages
English (en)
Inventor
Frank Prato
Donna Goldhawk
Cheryl Mccreary
Rebecca Mcgirr
Savita Dhanvantari
Terry Thompson
Alex Thomas
David Hill
Original Assignee
Multi Magnetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multi Magnetics Inc filed Critical Multi Magnetics Inc
Application granted granted Critical
Publication of ATE519777T1 publication Critical patent/ATE519777T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
AT07719932T 2006-06-08 2007-06-08 Magnetosomen-genexpression in eukaryotischen zellen ATE519777T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81178406P 2006-06-08 2006-06-08
US87979107P 2007-01-11 2007-01-11
PCT/CA2007/001016 WO2007140617A1 (en) 2006-06-08 2007-06-08 Magnetosome gene expression in eukaryotic cells

Publications (1)

Publication Number Publication Date
ATE519777T1 true ATE519777T1 (de) 2011-08-15

Family

ID=38801022

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07719932T ATE519777T1 (de) 2006-06-08 2007-06-08 Magnetosomen-genexpression in eukaryotischen zellen

Country Status (6)

Country Link
US (1) US9556238B2 (de)
EP (1) EP2029754B1 (de)
AT (1) ATE519777T1 (de)
AU (1) AU2007257180A1 (de)
CA (1) CA2655118C (de)
WO (1) WO2007140617A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0812191D0 (en) * 2008-07-03 2008-08-13 Greater Glasgow Health Board Modified cells and methods of monitoring their viability
US8580230B2 (en) 2009-02-23 2013-11-12 Kent State University Materials and methods for MRI contrast agents and drug delivery
US9719146B2 (en) 2009-09-09 2017-08-01 General Electric Company Composition and method for imaging stem cells
US10238886B2 (en) * 2009-11-18 2019-03-26 Nanobacterie Treatment of cancer or tumors induced by the release of heat generated by various chains of magnetosomes extracted from magnetotactic bacteria and submitted to an alternating magnetic field
US8956873B2 (en) 2012-01-13 2015-02-17 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US8828681B2 (en) 2012-01-13 2014-09-09 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US9023612B2 (en) 2012-01-13 2015-05-05 Bell Biosystems, Inc. Eukaryotic cells with artificial endosymbionts for multimodal detection
US10076579B2 (en) 2012-01-13 2018-09-18 Bell Biosystems, Inc. Host cells with artificial endosymbionts
WO2014145785A1 (en) 2013-03-15 2014-09-18 Bell Biosystems, Llc Host cells with artificial endosymbionts
AU2014315321A1 (en) 2013-09-03 2016-03-03 Bell Biosystems, Inc. Host cell modification with artificial endosymbionts
CA2940654A1 (en) * 2014-02-25 2015-09-03 Multi-Magnetics Incorporated Co-expression of magnetotactic bacterial genes and genes encoding iron handling proteins in cells
EP3747467A3 (de) * 2019-06-03 2021-03-03 Nanobacterie Kryosystem mit nanopartikeln zur behandlung eines körperteils eines individuums durch kryotherapie
WO2021076551A1 (en) * 2019-10-14 2021-04-22 University Of Cincinnati Novel rna aptamer intervenes estrogen receptor interaction with coactivator med1 to overcome breast cancer metastasis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62275679A (ja) * 1986-05-23 1987-11-30 Tdk Corp 磁気微粒子含有細胞の製法
US5861285A (en) 1994-09-16 1999-01-19 Tdk Corporation Fusion protein-bound magnetic particles for recombinant production and magnetic separation of polypeptides of interest
DE19716732C2 (de) 1997-03-07 1999-03-25 Max Delbrueck Centrum Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2002176989A (ja) 2000-12-14 2002-06-25 Japan Science & Technology Corp 磁気微粒子膜特異的タンパク質
WO2006119102A1 (en) * 2005-04-29 2006-11-09 Emory University Methods and compositions for the production and use of magnetosomes

Also Published As

Publication number Publication date
AU2007257180A1 (en) 2007-12-13
EP2029754A4 (de) 2009-07-08
US9556238B2 (en) 2017-01-31
EP2029754A1 (de) 2009-03-04
WO2007140617A1 (en) 2007-12-13
EP2029754B1 (de) 2011-08-10
CA2655118C (en) 2015-10-06
US20100297022A1 (en) 2010-11-25
CA2655118A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
ATE519777T1 (de) Magnetosomen-genexpression in eukaryotischen zellen
IL294095A (en) Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
TW200732347A (en) VEGF analogs and methods of use
CY1118984T1 (el) Παρασκευη ενεργων, ακρως φωσφορυλιωμενων, ανθρωπινων λυσοσωμικων ενζυμων σουλφατασης και χρησεις αυτων
AR081868A1 (es) Vectores y secuencias de sulfamidasa humana para el tratamiento de mucopolisacaridosis
EP2432462A4 (de) Endoxifen-verfahren und zusammensetzungen zur behandlung von säugererkrankungen
WO2006084209A3 (en) Rnai expression constructs
UY31816A (es) Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras
ES2422739T3 (es) Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCB
GB2472964A (en) Vectors for delivery of light-sensitive proteins and methods of use
BRPI1012129A2 (pt) enantiômeros de compostos spiro-oxindol e sua utilização como agentes terapêuticos.
EP2376655A4 (de) Genetische varianten der menschlichen kognition und verfahren zu ihrer verwendung als diagnostische und therapeutische ziele
EA201101522A1 (ru) Способы лечения болезней с использованием эпиметаболического переключателя (коэнзим q10)
SG10201508995QA (en) Targeted integration and expression of exogenous nucleic acid sequences
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
TR201905768T4 (tr) Kardiyovasküler, metabolik ve enflamatuar hastalık alanları ile ilişkili hastalıkların tedavisinde çoklu doymamış yağlı asitleri.
BRPI0923015A2 (pt) enxertos ósseos com atividade de protease reduzida e métodos de seleção e uso
EA201391154A2 (ru) Способы и композиции для нацеливания на адипоциты у млекопитающих
AU325686S (en) Spatula
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
HK1142608A1 (en) 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5-
EP2262777B8 (de) 1-benzyl-3-hydroxymethylindazolderivate und ihre verwendung bei der behandlung von auf der expression von mcp-1 und cx3cr1 basierten erkrankungen
WO2012048170A3 (en) Humanized animals via tissue engineering and uses therefor
ATE408398T1 (de) Nanopartikele für dna verabreichung zu einem zielorgan
EP2099465A4 (de) Reishi-vermittelte verstärkte adhäsion und differenzierung menschlicher gewebevorläuferzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties